Anchora Medical

Company Overview

Snapshot

Founded in October 2014 by Yoni Epstein, Anchora Medical operates with 1–10 employees and has raised $5.2M across 3 funding rounds from 5 investors.

Business overview

Anchora Medical develops minimally invasive suturing devices for endoscopic (GI) and laparoscopic (hernia) procedures. Their core technology involves sterile, automatic, single-use suturing devices that incorporate tiny stainless steel or nitinol anchors threaded on a surgical thread to create running or interrupted sutures. The company serves the healthcare industry, specifically targeting hospitals, surgeons, and gastroenterologists with its medical devices and surgical instruments.

Strategic signal

This investment signals continued investor confidence in the company's innovative minimally invasive surgical solutions and its potential for market expansion within the medical device sector.

Company Intelligence Q&A

What is Anchora Medical's primary product?

Anchora Medical's primary product is Su2ura Approximation Device, a minimally invasive surgical suturing device that received FDA clearance in June 2021.

When did Anchora Medical receive FDA clearance for its Su2ura device?

Anchora Medical received FDA clearance for its Su2ura Minimally-Invasive Surgical Suturing Device in June 2021.

Which investors participated in Anchora Medical's February 2020 financing round?

In February 2020, Anchora Medical closed a financing round led by.